File Download

There are no files associated with this item.

Supplementary

Conference Paper: 3-weekly Daratumumab-IMiD-dexamethasone is highly efficacious, hence financially affordable with enormous economic impacy for relapsed/ refractory Multiple Myeloma in less affluent counties

Title3-weekly Daratumumab-IMiD-dexamethasone is highly efficacious, hence financially affordable with enormous economic impacy for relapsed/ refractory Multiple Myeloma in less affluent counties
Authors
Issue Date2019
Citation
The 24th Congress of European Haematology Association (EHA), Amsterdam, the Netherlands, 13-16 June 2019 How to Cite?
DescriptionPoster Presentation - Abstract no PS1432
Persistent Identifierhttp://hdl.handle.net/10722/273441

 

DC FieldValueLanguage
dc.contributor.authorChim, JCS-
dc.contributor.authorWong, VKC-
dc.contributor.authorAu, YLE-
dc.contributor.authorKwong, YL-
dc.date.accessioned2019-08-06T09:29:01Z-
dc.date.available2019-08-06T09:29:01Z-
dc.date.issued2019-
dc.identifier.citationThe 24th Congress of European Haematology Association (EHA), Amsterdam, the Netherlands, 13-16 June 2019-
dc.identifier.urihttp://hdl.handle.net/10722/273441-
dc.descriptionPoster Presentation - Abstract no PS1432-
dc.languageeng-
dc.relation.ispartofThe 24th Congress of European Haematology Association (EHA)-
dc.title3-weekly Daratumumab-IMiD-dexamethasone is highly efficacious, hence financially affordable with enormous economic impacy for relapsed/ refractory Multiple Myeloma in less affluent counties-
dc.typeConference_Paper-
dc.identifier.emailChim, JCS: jcschim@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityChim, JCS=rp00408-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.hkuros299584-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats